Report Information More information from: https://www.wiseguyreports.com/reports/1170075-global-botulinum-toxin-market-2017-2021
Global Botulinum Toxin Market 2017-2021 Report / Search Code: WGR1170075
Price
1-user PDF : $ 3500.0
Description:
Publish Date: 5 April, 2017
1-5 User PDF : $ 4500.0
Enterprise PDF : $ 10000.0
ABSTRACT About Botulinum Toxin Botulinum toxin is a chemical substance, which is used as a drug to regulate the release of acetylcholine, the chemical that regulates the neuron flow in the nervous system to activate the muscles. To be used as a drug, botulinum toxin must be isolated, purified, and stabilized. This substance finds its place largely as one of the most sought-after muscle relaxants in the modern pharma industry for multiple indications such as cosmetic surgery, skeletal muscle relaxants, and neuromuscular relaxants to name a few. Technavio’s analysts forecast the global botulinum toxin market to grow at a CAGR of 8.16% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global botulinum toxin market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Botulinum Toxin Market 2017-2021, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • ALLERGAN • Galderma • Ipsen • Merz Pharma • Pfizer Other prominent vendors • Acorda Therapeutics • Aldeyra Therapeutics • Azidus Brasil • Biolab Sanus Farmaceutica • Canbex Therapeutics • DAEWOONG • Emcure Pharmaceuticals • Endo Pharmaceuticals International • Evolus • Fresenius Kabi • GlaxoSmithKline • INSYS THERAPEUTICS • Johnson & Johnson • Lannett • Lanzhou Institute of Biological Products • LEO Pharma • Mylan • Par Pharmaceuticals • PhytoTech Therapeutics • Revance Therapeutics
• Sun Pharmaceuticals • Takeda Pharmaceutical • UroGen Pharma Market driver • Rising demand for non-invasive solutions in cosmetology. • For a full, detailed list, view our report Market challenge • Side effects associated with the use of facial aesthetic products. • For a full, detailed list, view our report Market trend • Growing demand for anti-aging treatment. • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Contents:
Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: Botulinum toxin: An overview PART 06: Pipeline landscape PART 07: Market landscape • Five forces analysis PART 08: Market segmentation by drug categories • Aesthetic drugs market • Therapeutic drugs market PART 09: Geographical segmentation • Botulinum toxin market in Americas • Botulinum toxin market in EMEA • Botulinum toxin market in APAC PART 10: Decision framework PART 11: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 12: Market trends • Growing importance of medical aesthetics • Technological advancement • Growing demand for anti-aging treatment PART 13: Vendor landscape • Competitive landscape • Key news PART 14: Key vendor analysis • ALLERGAN • Galderma • Ipsen • Merz Pharma • Pfizer • Other prominent vendors PART 15: Appendix • List of abbreviations List of Exhibits Exhibit 01: Pipeline landscape Exhibit 02: Global botulinum toxin market: Snapshot Exhibit 03: Global botulinum toxin market 2016-2021 ($ millions) Exhibit 04: Global botulinum toxin market: Opportunity analysis
Exhibit 05: Five forces analysis Exhibit 06: Market segmentation by drug category 2016 Exhibit 07: Global aesthetic drugs market 2016-2021 ($ millions) Exhibit 08: Global therapeutic drugs market 2016-2021 ($ millions) Exhibit 09: Segmentation of global botulinum toxin market based on geography 2016 and 2021 Exhibit 10: Global botulinum toxin market revenue by geography 2016-2021 ($ millions) Exhibit 11: Market scenario in Americas Exhibit 12: Botulinum toxin market in Americas 2016-2021 ($ millions) Exhibit 13: Market scenario in EMEA Exhibit 14: Botulinum toxin market in EMEA 2016-2021 ($ millions) Exhibit 15: Market scenario in APAC Exhibit 16: Botulinum toxin market in APAC 2016-2021 ($ millions) Exhibit 17: Key R&D-based growth drivers Exhibit 18: Impact of drivers Exhibit 19: Impact of challenges Exhibit 20: Top five non-surgical procedures (injectable) of 2015 Exhibit 21: Competitive structure analysis of global botulinum toxin market 2016 Exhibit 22: Competitive analysis of global botulinum toxin market 2016 Exhibit 23: Global market penetration of players in botulinum toxin market 2016 Exhibit 24: ALLERGAN: Key highlights Exhibit 25: ALLERGAN: Strength assessment Exhibit 26: ALLERGAN: Strategy assessment Exhibit 27: ALLERGAN: Opportunity assessment Exhibit 28: Galderma: Key highlights Exhibit 29: Galderma: Strength assessment Exhibit 30: Galderma: Strategy assessment Exhibit 31: Galderma: Opportunity assessment Exhibit 32: Ipsen: Key highlights Exhibit 33: Ipsen: Strength assessment Exhibit 34: Ipsen: Strategy assessment Exhibit 35: Ipsen: Opportunity assessment Exhibit 36: Merz Pharma: Key highlights Exhibit 37: Merz Pharma: Strength assessment Exhibit 38: Merz Pharma: Strategy assessment Exhibit 39: Merz Pharma: Opportunity assessment Exhibit 40: Pfizer: Strength assessment Exhibit 41: Pfizer: Strategy assessment Exhibit 42: Pfizer: Opportunity assessment
wiseguyreports.com / Phone (US) + 1-646-845-9349 (UK) +44 208 133 9349